Transforming Access to Pharmacy Benefits: 2022 Drug Trend Report

We are pleased to share our 2022 Drug Trend Report with you. This year’s report highlights our success in managing pharmacy benefit costs for our clients.

Through our efforts, Navitus’ commercial clients experienced an average net total per member per month (PMPM) cost of only $89.73, with a drug trend of only 2.6%. As a result, 49% of Navitus employer plan sponsors and commercial plans saw their net drug spending decrease compared to 2021. Navitus was able to control client costs thanks to:

Improved pharmacy network rates combined with increased rebates and manufacturer fees. Amid the highly inflationary brand medication market, these contract enhancements resulted in significant savings that were immediately passed through to clients.

Appropriate formulary and utilization management. Coverage recommendations to manage utilization growth of high-cost brand products helped minimize impact in some faster-growing drug categories such as migraine and diabetes.

The last year was undeniably exceptional in its complexities and challenges. 2022 saw notable increases in both drug list prices and utilization across a wide range of covered medications. Specialty medications accounted for over 50% of total spending for commercial plans, despite only representing about 1% of overall utilization.

As we chart a path forward, several future trends warrant particular attention:

The launch of biosimilar products for Humira® (adalimumab), the highest spend product on the market today, could significantly reduce drug spend for some clients. The first was released in February 2023 and several more will be released in July 2023.

The availability of new generics for treating major depressive disorders and ADHD has the potential to lower costs in this category in late 2023 and 2024.

New treatments for inflammatory skin conditions that previously lacked effective treatment could drive up the cost of dermatology medications.

Therapeutic breakthroughs and growing clinical acceptance have increased the demand for chronic weight management treatments.

Explore the Navitus 2022 Drug Trend Report to discover more about what we have been able to achieve in partnership with our clients and in service to our members.

1. Net total cost paid by plans and membership minus manufacturer rebates.

Stay Informed and Connected

Receive expert insights, healthcare tips, and important updates on pharmacy benefits, drug recalls, and more—straight to your inbox.

Examining Trends that Drive Informed Decisions

Now Available: 8th Annual Drug Trend Report

See the latest results and access industry insights you need to navigate current trend drivers.

Related blogs

Navigating Healthcare and Improving Outcomes

Achieving Outstanding Results with Tailored Network Strategies

Achieving Outstanding Results with Tailored Network Strategies

A medium-sized city in Michigan with 1,350 members was seeking ways to lower its pharmacy benefit costs, which were growing under its existing traditional pharmacy benefit manager (PBM). With its member covered by a two-tier, open formulary including…

Breaking Through Barriers with Value-Based Plan Design

Breaking Through Barriers with Value-Based Plan Design

Facing increased pharmacy benefit expenses, Blain’s Farm and Fleet, a Midwestern employer group, desired to improve plan performance. Specifically it was interested in educating eligible members about the benefits available to them, promoting cost-effective…

Finding a Solution to Lower Prescription Drug Costs

Finding a Solution to Lower Prescription Drug Costs

The Rural Arizona Group Health Trust (RAGHT) wanted to gain better control of its escalating drug trend with its large, traditional pharmacy benefit manager (PBM). Having only worked with traditional PBMs in the past, RAGHT was interested in exploring…

Empowered by Strategic Opportunities and Service Excellence

Empowered by Strategic Opportunities and Service Excellence

Putnam | Northern Westchester Health Benefits Consortium (PNW HBC) was the first municipal cooperative health plan in the state of New York to become certified by the Department of Insurance. They are dedicated to meeting — and exceeding — the standards…

QUALYiQ Program Delivers Significant Savings for Both Members and Health Plans

QUALYiQ Program Delivers Significant Savings for Both Members and Health Plans

As part of their treatment plan for hypophosphatasia (HPP), a rare genetic disorder affecting bone and teeth development, one of our members required Strensiq, a medication designed to manage HPP. However, Strensiq’s annual treatment costs ranged from…

RISE: Reporting and Intervention for Stars Excellence

RISE: Reporting and Intervention for Stars Excellence

RISE is a comprehensive Star Ratings Improvement program that focuses on positive outcomes for Medicare Part D (Part D) clinical measures, including: medication adherence for diabetes medications, medication adherence for hypertension, medication adherence…

Medication Therapy Management: Improving Health Outcomes and Reducing Cost

Medication Therapy Management: Improving Health Outcomes and Reducing Cost

Patients with chronic diseases can face greater risks for medication-related challenges such as non-adherence. This can lead to poor health outcomes and higher plan costs. That’s why we developed an MTM program, offered through our Clinical Engagement…

Personalized Member Transitions: Creating a Smoother Benefit Transition

Personalized Member Transitions: Creating a Smoother Benefit Transition

Navigating benefit transitions is no easy task. Our personalized member transition (PMT) program makes it smoother for both plan sponsors and members. Through our high-touch outreach to members, we eliminate gaps in care, minimize member disruption, improve…

Pharmacy and Practitioner Exclusions and How to Resolve Them

Pharmacy and Practitioner Exclusions and How to Resolve Them

Prescribers and Pharmacies can be deemed ineligible for providing services to government programs like Medicare, Medicaid or even to payers who are participating in government programs. Being ineligible to provide those services is commonly referred to…

previous arrow
next arrow